Skip to main content
Premium Trial:

Request an Annual Quote

Dutch Medical Center to Use Oracle's Infrastructure for Personalized Medicine Research


NEW YORK (GenomeWeb) – Oracle said this week that Erasmus University Medical Center Rotterdam has selected the Oracle Health Sciences Translational Research Center and the Oracle Exadata Database Machine to support research projects focused on personalized medicine and better patient outcomes.

Erasmus chose its solution because of its ability to simultaneously query clinical and omics data, which "will be vital to advancing our next-generational genomics research initiatives," Jan Hazelzet, Erasmus' chief medical information officer, said in a statement. "As we expand the deployment across our enterprise, the platform's centralized data warehouse will enable in-depth analysis of patient outcomes and cost of care from a single source."

Oracle said that Erasmus will use the solution to analyze clinical and omics data to identify new biomarkers that could help clinicians make more personalized treatment recommendations. Erasmus' first project on the Oracle platform will focus on improving care and outcomes for patients with craniofacial malformations. The initiative will involve performing whole genome sequencing on over 1,000 patients, according to Oracle. Erasmus will also use the platform to explore the cost-effectiveness of specific treatments.

Financial and other terms of the agreement were not disclosed.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.